Product Release Timed For Diabetes Awareness Month
SIOUX FALLS, S.D., Nov. 17, 2011 /PRNewswire-iReach/ — A South Dakota pharmaceutical company, pharmaCline((TM)), is doing its part for National Diabetes Month by launching a new antibiotic called Diabecline(Ã‚®) to help diabetic patients with foot problems. Diabetes affects at least 25 million citizens in the United States, in addition to 79 million Americans who are pre-diabetic.
(Photo: <font size=”2″ face=”Arial”>http://photos.prnewswire.com/prnh/20111117/CG09555)</font>
Diabetic foot problems like ulcerations, infections and gangrene are the most common cause of hospitalization among diabetes patients. pharmaCline, an innovative pharmaceutical company, has developed a new drug delivery technology, known as Site Specific Penetration Technology (SSPT((TM))), for use with over-the-counter (OTC) topical antibiotic drugs. The company released three new products for sale in November to coincide with National Diabetes Month. Diabecline is designed for use by both diabetics and pre-diabetics for the treatment of minor cuts, scrapes and burns. pharmaCline’s OTC topical antibiotics are designed to help reduce the incidence of minor injuries from becoming more serious due to infections.
“Our Diabecline antibiotic allows users who are at greater risk of developing serious infections to achieve better care,” said Steve Keough, Chief Executive Officer at pharmaCline. The two other products, Tissecline(Ã‚®) and TisseclinePlus(Ã‚®), were also released for sale in November. Diabecline and all other pharmaCline products are available to consumers on Amazon.com via the pharmaCline website, www.pharmacline.com.
Diabetes is categorized into two types, Type I and Type II. Type I Diabetes, formerly known as Juvenile Diabetes, occurs when the body does not produce sufficient amounts of insulin and requires insulin therapy. Type II Diabetes, the more prevalent of the two, is a condition that is usually diagnosed in older individuals. Type II causes body cells to become resistant to the action of insulin rendering insulin ineffective.
Some groups have a higher pre-disposition to becoming diabetic. These include Native Americans, Hispanic Americans and African Americans. However, all people are at a higher rate for diabetes if they are overweight.
“Diabecline antibiotic is the perfect gift for the holidays and to start the new year” said Lana McCoy, Executive Marketing Coordinator for pharmaCline. “When used as a preventive product on wounds it’s like giving the gift of good health to someone you care about.”
The launch of pharmaCline’s products within National Diabetes Month is consistent with its mission of healing wounds, preventing disease and improving lives. In October and November, pharmaCline presented the results of its elderly diabetic extremity wound care research at leading medical symposia. pharmaCline also provides support to various non-profit organizations with missions of education and awareness concerning diabetes, wounds and infection control.
Media Contact: Lana McCoy pharmaCline, 605-201-0931, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com